- Researchers report that a new blood test detected 93% of stage 1 cancers in men and 84% among women.
- The researchers used the test to analyze a wide range of protein-based biomarkers.
- They said the test detected cancer for many forms of the disease for which no effective screenings now exist.
A new blood test could be used for early detection of 18 different types of cancer, a new study published in the journal BMJ Oncology reports.
In developing the test, the researchers focused on the
The gender-specific
The analysis of 150 biomarkers also allowed researchers to pinpoint the origin of cancers to specific organs in more than 80% of cases, Afshin and colleagues reported.
“The proteome-based screening test showed promising performance compared with other technologies and could be a starting point for developing a new generation of screening tests for the early detection of cancer,” the study authors wrote.
“Early detection is the key to good cancer outcomes,” Dr. Misagh Karimi, a medical oncologist at City of Hope Orange County Lennar Foundation Cancer Center in California, told Medical News Today.
“The possibility of being able to identify 18 different early-stage cancers, as described in this new study, is a potential game-changer that could lead to innovation in screenings, targeted treatments, and more,” said Karimi, who was not involved in the study. “However, this is an evolving area of research in which further studies on multi-cancer early detection tests need to be done.”
In…
Read the full article here